| Entry |
|
|---|
| Name |
Centanafadine (USAN/INN) |
|---|
| Formula |
C15H15N
|
|---|
| Exact mass |
209.1204
|
|---|
| Mol weight |
209.29
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG03059 Noradrenalin and dopamine reuptake inhibitor (NDRI)
|
|---|
| Remark |
|
|---|
| Efficacy |
Noradrenalin and dopamine reuptake inhibitor |
|---|
| Comment |
Treatment of attention deficit hyperactivity disorder (ADHD)
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03059 Noradrenalin and dopamine reuptake inhibitor (NDRI)
DG01858 Centanafadine
D10697 Centanafadine
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (NAT1)
D10697 Centanafadine (USAN/INN)
SLC6A3 (DAT1)
D10697 Centanafadine (USAN/INN)
SLC6A4 (HTT)
D10697 Centanafadine (USAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03059 Noradrenalin and dopamine reuptake inhibitor (NDRI)
DG01858 Centanafadine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 16
1 C8y C 20.5504 -16.5693
2 C8y C 20.5504 -17.9676
3 C8x C 19.3619 -18.6667
4 C8x C 18.1035 -17.9676
5 C8y C 18.1035 -16.5693
6 C8x C 19.3619 -15.8702
7 C1z C 16.9150 -15.8702
8 C1y C 15.5168 -15.8702
9 C1x C 16.2159 -17.0587
10 C1x C 17.3345 -14.5419
11 N1x N 16.2159 -13.7029
12 C1x C 15.0274 -14.5419
13 C8x C 21.7613 -18.6667
14 C8x C 22.9723 -17.9676
15 C8x C 22.9723 -16.5693
16 C8x C 21.7613 -15.8702
BOND 19
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 7 5 1 #Up
8 7 8 1
9 8 9 1
10 9 7 1
11 7 10 1
12 10 11 1
13 11 12 1
14 8 12 1
15 2 13 1
16 13 14 2
17 14 15 1
18 15 16 2
19 1 16 1
|
|---|
